The US is at risk for dengue fever
The buzz surrounding the mosquito-borne illness


As the weather warms, mosquitos are expanding their range. With that, mosquito-borne illnesses are also becoming more commonplace. The newest risk to the U.S. is dengue fever, the instances of which have skyrocketed in 2024. The disease has the potential to be deadly if left untreated and is likely going to become more routine as climate change worsens.
What is dengue fever?
Dengue fever is a mosquito-borne viral illness mostly present in tropical climates. However, the U.S. has begun to see a spike in cases amid warming temperatures. According to the Centers for Disease Control and Prevention (CDC), the U.S. saw a "higher-than-expected" 2,241 new cases, including 1,498 in Puerto Rico between January 1 and July 24, 2024. The highest number of cases in the continental U.S. was seen in Florida, New York and Massachusetts. The problem is not just limited to the U.S. "As of June 24, 2024, more than 9.7 million dengue cases have been reported in the Americas, twice as many as in all of 2023," the CDC said.
Dengue fever is spread through the Aedes species of mosquito. Symptoms of the disease can "present as fever accompanied by non-specific signs and symptoms such as nausea, vomiting, rash, muscle aches, joint pain, bone pain, pain behind the eyes, headache or low white blood cell counts," said the CDC. However, approximately 5% of cases can progress to severe dengue which can cause "plasma, the protein-rich fluid component of blood, to leak out of blood vessels," said The New York Times. "Some patients may go into shock, causing organ failure." The good news is that only one in four cases of dengue fever are symptomatic at all and even severe cases have a high rate of survival, if treated.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Is there a cure?
There are no antiviral medications that have been approved to treat dengue fever. Instead symptoms are managed with medication like acetaminophen and patients are advised to rest, stay hydrated and closely monitor conditions. Severe cases may require hospitalization. Some antivirals are currently in clinical trials.
Prevention is the best option. Experts recommend "staying in places with air conditioning when possible, using insect repellent and wearing long sleeves and pants to avoid mosquito bites," said NBC News. There is one approved vaccine for dengue fever, but it is only recommended for ages 6 to 16 years in locations with high transmission levels. Infants, the elderly and pregnant people are most at risk of contracting severe dengue.
What about the future?
Climate change does not spell optimism for mosquito-borne illnesses. "Dengue cases are likely to increase as global temperatures increase," said the CDC. "Higher temperatures can expand the range of the mosquitoes that spread dengue, as well as affect other factors that facilitate virus transmission like faster viral amplification in the mosquito, increased vector survival and changes in reproduction and biting rates." As of now, most dengue cases in the U.S. are the result of travel, but local outbreaks are starting to become more customary.
In addition, "the spread of the disease has been exacerbated by increasingly wet and warm summer months brought forward by El Niño," said Time. The U.S. is not at severe risk just yet, thanks to air conditioning and screened windows limiting exposure to mosquitos. Cases should stay low "as long as people keep living like they're living now," Thomas W. Scott, a dengue epidemiologist and professor emeritus at the University of California, Davis, said to the Times.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
July 19 editorial cartoons
Cartoons Saturday’s political cartoons include a Medicaid time bomb, and Donald Trump's fixation with the Fed's Jerome Powell
-
5 hilariously cutting cartoons about the Department of Education
Cartoons Artists take on being rotten to the core, budget cuts, and more
-
Kartoffelsalat (potato salad) recipe
The Week Recommends German dish is fresh, creamy and an ideal summer meal
-
Children's health has declined in the US
The Explainer It's likely a sign of larger systemic issues
-
Cytomegalovirus can cause permanent birth defects
The Explainer The virus can show no symptoms in adults
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Is that the buzzing sound of climate change worsening sleep apnea?
Under the radar Catching diseases, not those ever-essential Zzs
-
Deadly fungus tied to a pharaoh's tomb may help fight cancer
Under the radar A once fearsome curse could be a blessing
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
A disproven medical theory could be guiding RFK Jr.'s health policy
The Explainer The miasma theory is one of the oldest medical beliefs in history
-
Climate change can impact our gut health
Under the radar The gastrointestinal system is being gutted